Ernexa Therapeutics appoints Robert J. Spiegel to board of directors
ERNA•Ernexa Therapeutics appointed Robert J. Spiegel to its board as it sharpens its oncology focus and advances ERNA-101. Spiegel spent more than 25 years at Schering-Plough Research Institute, most recently serving as chief medical officer.
1. Board appointment
Ernexa Therapeutics appointed Robert J. Spiegel to its board as it sharpens its oncology focus and advances ERNA-101. Spiegel spent more than 25 years at Schering-Plough Research Institute, most recently serving as chief medical officer.
